Allogeneic stem cell transplantation from donors with mosaic Turner syndrome [1]

Bone Marrow Transplantation

Volumn 38, Issue 5, 2006, Pages 385-386

  Manola, K N ^a   Sambani, C ^a   Karakasis, D ^b   Baltathakis, I ^b   Zoumbos, N ^c   Symeonidis, A ^c  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA FRAGMENT; GLUCOCORTICOID; HLA A ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGRAFT; CASE REPORT; CHIMERA; CHROMOSOME MOSAICISM; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOGENETICS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DNA POLYMORPHISM; DONOR; FEMALE; HLA MATCHING; HUMAN; IMMUNOPROPHYLAXIS; KARYOTYPE; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MYELOABLATIVE CONDITIONING; OSTEOPOROSIS; PRIORITY JOURNAL; SHORT TANDEM REPEAT; SKIN DEFECT; STEROID THERAPY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TURNER SYNDROME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MOSAICISM; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TURNER SYNDROME;

EID: 33747345984     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705456     Document Type: Letter

References (8)

1. Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner's syndrome in adulthood. Endocr Rev 2002; 23: 120-140.
2. Gupta S, Chiplunkar S, Gupta A, Gollapudi S. Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun 2003; 4: 239-243.
3. Saito T, Usui N, Asai O, Yano S, Sugiyama K, Hisatomi M et al. Toxicity and outcome of intensive chemotherapy for acute lymphoblastic leukemia complicated with Turner's syndrome. Intern Med 2005; 44: 145-148.
4. Cacciari E, Masi M, Fantini MP, Licastro F, Cicognani A, Pirazzoli P et al. Serum immunoglobulins and lymphocyte subpopulations derangement in Turner's syndrome. J Immunogenet 1981; 8: 337-344.
5. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis Int 2003; 14: 617-630.
6. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: Results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898-1906.
7. Traggiai C, Stanhope R, Nussey S, Leiper AD. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 2003; 40: 128-129.
8. Shen H, Zhang YY, Long JR, Xu FH, Liu YZ, Mao P et al. A genome-wide linkage scan for bone mineral density in an extended sample: Evidence for linkage on 11q23 and Xq27. J Med Genet 2004; 41: 743-751.